6761-50-8 Usage
General Description
Pyrazinecarboxylic acid, 3-amino-5-methyl- (7CI,8CI,9CI) is a chemical compound with the molecular formula C7H8N2O2. It is a derivative of pyrazinecarboxylic acid, with an amino group and a methyl group attached to the third and fifth carbon atoms, respectively. Pyrazinecarboxylic acid, 3-amino-5-methyl- (7CI,8CI,9CI) is often used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It has potential applications in the pharmaceutical industry, particularly in the development of new drugs and medical treatments. Additionally, it may also have uses in the fields of agriculture and chemical research. However, as with any chemical compound, proper handling and safety precautions should be observed when using pyrazinecarboxylic acid, 3-amino-5-methyl- to prevent potential hazards and health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 6761-50-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,7,6 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6761-50:
(6*6)+(5*7)+(4*6)+(3*1)+(2*5)+(1*0)=108
108 % 10 = 8
So 6761-50-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O2/c1-3-2-8-4(6(10)11)5(7)9-3/h2H,1H3,(H2,7,9)(H,10,11)
6761-50-8Relevant articles and documents
-
Cain et al.
, p. 3026,3028 (1948)
-
THIAZOLIUMS AS TRANSKETOLASE INHIBITORS
-
Page/Page column 39, (2008/06/13)
The present invention provides N-3'-pyridylmethyl or N-2'-pyrazinylmethyl thiazolium derivatives of formula (I) which are useful as transketolase inhibitors wherein R1, R2, R3, Y, R5-R9, Ra-Rd, n and X- are as defined herein. The present invention also provides pharmaceutical compositions comprising the compounds of formula (I). The invention provides methods for inhibiting transketolase activity, reducing cellular ribose-5-phosphate levels, inhibiting nucleic acid synthesis, inhibiting cell proliferation and tumor cell growth in vitro and in vivo, stimulating apoptosis in tumor cells and treating cancer by administering a compound of formula (I) or a pharmaceutical composition thereof.
